Study of Ebronucimab injection in healthy men
This trial tests a single shot of a new medicine called Ebronucimab in healthy Chinese men. It aims to check how the body handles the drug and what effects it may have. It may help lower cholesterol in the future.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a healthy Chinese man
- You weigh between 132 and 176 pounds
- Your body mass index (BMI) is between 19 and 26
- Your LDL cholesterol level is between 1.8 and 4.9 mmol/L
- You have not used PCSK9 inhibitor drugs in the past year
- You are not allergic to any of the ingredients in the drug
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This is an early-stage safety study testing a new monoclonal antibody (a type of protein medicine) called ISH0613 in healthy volunteers. The study will look at how safe the drug is, how your body handles it, and what effects it has.
This study tests a new medicine called BEBT-701 for people with mild to moderate high blood pressure and high cholesterol. The goal is to see if it can lower both blood pressure and LDL ('bad') cholesterol safely.
This trial tests a single dose of an experimental medicine called EB070 in healthy people. It checks how the drug moves through the body and if it causes side effects. You may be able to join if you are a generally healthy adult.
This trial tests a new medicine called HB0034 in healthy volunteers. It helps researchers understand how the drug works in the body before testing it in people with a medical condition.
This study looks at how a new drug (RAY1225) leaves the body after a single injection. It involves healthy volunteers to track the drug over time and understand its safety.
This study tests how a new medicine (BI 3034701) moves through the body in healthy men who have normal weight or are overweight. It helps find the right dose and understand how the medicine works.
Hear when a new Healthy Subjects (HS) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.